Exosome RNA Exosome RNA Research & Industry News
Regenerative medicine company Exopharm Limited (ASX:EX1) announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes...
Read More »First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study
Don't Miss
- Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease
- Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines
- Extracellular vesicles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
- Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches
- HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment
- NVIGEN unveils groundbreaking comprehensive liquid biopsy – multimodal biomarker detection enabled by highly versatile nanoparticle capture
- SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes
- Extracellular vesicles: biological packages that modulate tumor cell invasion
- Researchers warn – direct-to-consumer businesses promoting unproven stem cell, exosome and gene-based interventions
- Study shows how aging affects communication between skin cells